NFκB and STAT3 synergistically activate the expression of FAT10, a gene counteracting the tumor suppressor p53

Molecular Oncology

Volumn 8, Issue 3, 2014, Pages 642-655

  Choi, Yongwook ^a   Kim, Jong Kyoung ^b   Yoo, Joo Yeon ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

FAT10; Inflammation; P53; STAT3; Tumorigenesis

Indexed keywords

FAT10 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PROTEIN; PROTEIN P53; STAT3 PROTEIN; UNCLASSIFIED DRUG; STAT1 PROTEIN; UBD PROTEIN, HUMAN; UBIQUITIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CARCINOGENESIS; CHRONIC INFLAMMATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SOLID TUMOR; TUMOR GROWTH; ANIMAL; C57BL MOUSE; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; HEPG2 CELL LINE; HUMAN; IMMUNOLOGY; NEOPLASM; NUCLEOTIDE SEQUENCE; TRANSCRIPTION INITIATION;

ANIMALS; BASE SEQUENCE; CELL LINE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; NEOPLASMS; NF-KAPPA B; PROMOTER REGIONS, GENETIC; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITINS;

EID: 84899493959     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2014.01.007     Document Type: Article

References (51)

1. Aggarwal B.B., Shishodia S., Sandur S.K., Pandey M.K., Sethi G. Inflammation and cancer: how hot is the link?. Biochem. Pharmacol. 2006, 72:1605-1621.
2. Benjamini Y., Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J.Roy Stat. Soc. B Met. 1995, 57:289-300.
3. Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., Darnell J.E. Stat3 as an oncogene. Cell 1999, 98:295-303.
4. Brown K., Park S., Kanno T., Franzoso G., Siebenlist U. Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proc. Natl. Acad. Sci. U S A 1993, 90:2532-2536.
5. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
6. Dawn B., Xuan Y.T., Guo Y., Rezazadeh A., Stein A.B., Hunt G., Wu W.J., Tan W., Bolli R. IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. Cardiovasc. Res. 2004, 64:61-71.
7. DiDonato J.A., Mercurio F., Karin M. NF-kappaB and the link between inflammation and cancer. Immunol. Rev. 2012, 246:379-400.
8. Gong P., Canaan A., Wang B., Leventhal J., Snyder A., Nair V., Cohen C.D., Kretzler M., D'Agati V., Weissman S., Ross M.J. The ubiquitin-like protein FAT10 mediates NF-kappaB activation. J.Am. Soc. Nephrol. 2010, 21:316-326.
9. Gorina R., Petegnief V., Chamorro A., Planas A.M. AG490 prevents cell death after exposure of rat astrocytes to hydrogen peroxide or proinflammatory cytokines: involvement of the Jak2/STAT pathway. J.Neurochem. 2005, 92:505-518.
10. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell 2010, 140:883-899.
11. Grivennikov S.I., Karin M. Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev. 2010, 21:11-19.
12. Grivennikov S.I., Karin M. Inflammation and oncogenesis: a vicious connection. Curr. Opin. Genet. Dev. 2010, 20:65-71.
13. Gudkov A.V., Gurova K.V., Komarova E.A. Inflammation and p53: a tale of two stresses. Genes Cancer 2011, 2:503-516.
14. Hu X., Ivashkiv L.B. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity 2009, 31:539-550.
15. Huang S., Bucana C.D., Van Arsdall M., Fidler I.J. Stat1 negatively regulates angiogenesis, tumorigenicity and metastasis of tumor cells. Oncogene 2002, 21:2504-2512.
16. Hutchins A.P., Poulain S., Miranda-Saavedra D. Genome-wide analysis of STAT3 binding invivo predicts effectors of the anti-inflammatory response in macrophages. Blood 2012, 119:e110-119.
17. Issaeva N., Bozko P., Enge M., Protopopova M., Verhoef L.G., Masucci M., Pramanik A., Selivanova G. Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors. Nat. Med. 2004, 10:1321-1328.
18. Ji F., Jin X., Jiao C.H., Xu Q.W., Wang Z.W., Chen Y.L. FAT10 level in human gastric cancer and its relation with mutant p53 level, lymph node metastasis and TNM staging. World J. Gastroenterol. 2009, 15:2228-2233.
19. Kundu J.K., Surh Y.J. Emerging avenues linking inflammation and cancer. Free Radic. Biol. Med. 2012, 52:2013-2037.
20. Kuraishy A., Karin M., Grivennikov S.I. Tumor promotion via injury- and death-induced inflammation. Immunity 2011, 35:467-477.
21. Lassmann S., Schuster I., Walch A., Gobel H., Jutting U., Makowiec F., Hopt U., Werner M. STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation. J.Clin. Pathol. 2007, 60:173-179.
22. Lee C.G., Ren J., Cheong I.S., Ban K.H., Ooi L.L., Yong Tan S., Kan A., Nuchprayoon I., Jin R., Lee K.H., Choti M., Lee L.A. Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers. Oncogene 2003, 22:2592-2603.
23. Lee H., Deng J., Xin H., Liu Y., Pardoll D., Yu H. A requirement of STAT3 DNA binding precludes Th-1 immunostimulatory gene expression by NF-kappaB in tumors. Cancer Res. 2011, 71:3772-3780.
24. Lee H., Herrmann A., Deng J.H., Kujawski M., Niu G., Li Z., Forman S., Jove R., Pardoll D.M., Yu H. Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. Cancer Cell 2009, 15:283-293.
25. Li N., Grivennikov S.I., Karin M. The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment. Cancer Cell 2011, 19:429-431.
26. Li T., Santockyte R., Yu S., Shen R.F., Tekle E., Lee C.G., Yang D.C., Chock P.B. FAT10 modifies p53 and upregulates its transcriptional activity. Arch. Biochem. Biophys. 2011, 509:164-169.
27. Liu Y., Li P.K., Li C., Lin J. Inhibition of STAT3 signaling blocks the anti-apoptotic activity of IL-6 in human liver cancer cells. J.Biol. Chem. 2010, 285:27429-27439.
28. Lu H., Ouyang W., Huang C. Inflammation, a key event in cancer development. Mol. Cancer Res. 2006, 4:221-233.
29. Lukasiak S., Schiller C., Oehlschlaeger P., Schmidtke G., Krause P., Legler D.F., Autschbach F., Schirmacher P., Breuhahn K., Groettrup M. Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon. Oncogene 2008, 27:6068-6074.
30. Mathews L.A., Hurt E.M., Zhang X., Farrar W.L. Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells. Mol. Cancer 2010, 9:267.
31. Narimatsu M., Maeda H., Itoh S., Atsumi T., Ohtani T., Nishida K., Itoh M., Kamimura D., Park S.J., Mizuno K., Miyazaki J., Hibi M., Ishihara K., Nakajima K., Hirano T. Tissue-specific autoregulation of the stat3 gene and its role in interleukin-6-induced survival signals in T cells. Mol. Cell Biol. 2001, 21:6615-6625.
32. Niu G., Wright K.L., Ma Y., Wright G.M., Huang M., Irby R., Briggs J., Karras J., Cress W.D., Pardoll D., Jove R., Chen J., Yu H. Role of Stat3 in regulating p53 expression and function. Mol. Cell Biol. 2005, 25:7432-7440.
33. Oeckinghaus A., Hayden M.S., Ghosh S. Crosstalk in NF-kappaB signaling pathways. Nat. Immunol. 2011, 12:695-708.
34. Oh Y.M., Kim J.K., Choi Y., Choi S., Yoo J.Y. Prediction and experimental validation of novel STAT3 target genes in human cancer cells. PloS One 2009, 4:e6911.
35. Ory K., Legros Y., Auguin C., Soussi T. Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation. EMBO J. 1994, 13:3496-3504.
36. Raasi S., Schmidtke G., Groettrup M. The ubiquitin-like protein FAT10 forms covalent conjugates and induces apoptosis. J.Biol. Chem. 2001, 276:35334-35343.
37. Ren J., Wang Y., Gao Y., Mehta S.B., Lee C.G. FAT10 mediates the effect of TNF-alpha in inducing chromosomal instability. J.Cell Sci. 2011, 124:3665-3675.
38. Schneider C.A., Rasband W.S., Eliceiri K.W. NIH image to ImageJ: 25 years of image analysis. Nat. Methods 2012, 9:671-675.
39. Seo S.H., Kim K.S., Park S.H., Suh Y.S., Kim S.J., Jeun S.S., Sung Y.C. The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity. Gene Ther. 2011, 18:488-495.
40. Song J.Y., Han H.S., Sabapathy K., Lee B.M., Yu E., Choi J. Expression of a homeostatic regulator, Wip1 (wild-type p53-induced phosphatase), is temporally induced by c-Jun andp53 in response to UV irradiation. J.Biol. Chem. 2010, 285:9067-9076.
41. Souissi I., Ladam P., Cognet J.A., Le Coquil S., Varin-Blank N., Baran-Marszak F., Metelev V., Fagard R. A STAT3-inhibitory hairpin decoy oligodeoxynucleotide discriminates between STAT1 and STAT3 and induces death in a human colon carcinoma cell line. Mol. Cancer 2012, 11:12.
42. Tergaonkar V., Pando M., Vafa O., Wahl G., Verma I. p53 stabilization is decreased upon NFkappaB activation: a role for NFkappaB in acquisition of resistance to chemotherapy. Cancer Cell 2002, 1:493-503.
43. Trinchieri G. Cancer and inflammation: an old intuition with rapidly evolving new concepts (*). Annu. Rev. Immunol. 2012, 30:677-706.
44. Wang W.B., Levy D.E., Lee C.K. STAT3 negatively regulates type I IFN-mediated antiviral response. J.Immunol. 2011, 187:2578-2585.
45. Wang X., Liu Q., Ihsan A., Huang L., Dai M., Hao H., Cheng G., Liu Z., Wang Y., Yuan Z. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin. Toxicol. Sci. An Official J. Soc. Toxicol. 2012, 127:412-424.
46. Wu Z.J., Irizarry R.A., Gentleman R., Martinez-Murillo F., Spencer F. A model-based background adjustment for oligonucleotide expression arrays. J.Am. Stat. Assoc. 2004, 99:909-917.
47. Xu X., Kasembeli M.M., Jiang X., Tweardy B.J., Tweardy D.J. Chemical probes that competitively and selectively inhibit Stat3 activation. PloS One 2009, 4:e4783.
48. Yamamoto Y., Verma U.N., Prajapati S., Kwak Y.T., Gaynor R.B. Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression. Nature 2003, 423:655-659.
49. Yang J., Liao X., Agarwal M.K., Barnes L., Auron P.E., Stark G.R. Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Genes Dev. 2007, 21:1396-1408.
50. Yu H., Pardoll D., Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat. Rev. Cancer 2009, 9:798-809.
51. Zhang D.W., Jeang K.T., Lee C.G. p53 negatively regulates the expression of FAT10, a gene upregulated in various cancers. Oncogene 2006, 25:2318-2327.